| Head and Neck Cancer Studies | Lifetime | 20 | NL 2 | 99.86 |
| Oral health in cancer treatment | Lifetime | 4 | NL 1 | 99.67 |
| Advanced Radiotherapy Techniques | Lifetime | 32 | NL 3 | 99.74 |
| Radiation Therapy and Dosimetry | Lifetime | 29 | NL 2 | 99.40 |
| Dysphagia Assessment and Management | Lifetime | 41 | NL 5 | 99.09 |
| Lung Cancer Diagnosis and Treatment | Lifetime | 159 | NL 13 | 99.46 |
| Radiomics and Machine Learning in Medical Imaging | Lifetime | 275 | NL 25 | 99.00 |
| Head and Neck Surgical Oncology | Lifetime | 151 | NL 4 | 99.08 |
| Medical Imaging Techniques and Applications | Lifetime | 414 | NL 23 | 98.59 |
| Salivary Gland Tumors Diagnosis and Treatment | Lifetime | 177 | NL 8 | 98.66 |
| Management of metastatic bone disease | Lifetime | 135 | NL 6 | 98.01 |
| Effects of Radiation Exposure | Lifetime | 149 | NL 5 | 97.86 |
| Lung Cancer Treatments and Mutations | Lifetime | 845 | NL 22 | 98.31 |
| Cancer survivorship and care | Lifetime | 478 | NL 21 | 97.13 |
| Cancer Diagnosis and Treatment | Lifetime | 841 | NL 32 | 96.25 |
| Ear and Head Tumors | Lifetime | 281 | NL 12 | 97.07 |
| Esophageal Cancer Research and Treatment | Lifetime | 766 | NL 56 | 96.40 |
| Voice and Speech Disorders | Lifetime | 415 | NL 14 | 95.92 |
| Advances in Oncology and Radiotherapy | Lifetime | 334 | NL 10 | 93.90 |
| Colorectal and Anal Carcinomas | Lifetime | 962 | NL 54 | 95.05 |
| Brain Metastases and Treatment | Lifetime | 897 | NL 34 | 94.85 |
| Salivary Gland Disorders and Functions | Lifetime | 679 | NL 34 | 93.70 |
| Advanced Radiotherapy Techniques | 2021-2025 | 11 | NL 1 | 99.46 |
| Head and Neck Cancer Studies | 2021-2025 | 15 | NL 1 | 99.49 |
| Radiation Therapy and Dosimetry | 2021-2025 | 12 | NL 1 | 99.02 |
| Lung Cancer Diagnosis and Treatment | 2021-2025 | 229 | NL 13 | 97.51 |
| Oral health in cancer treatment | 2021-2025 | 22 | NL 3 | 95.35 |
| Medical Imaging Techniques and Applications | 2021-2025 | 310 | NL 23 | 95.88 |
| Advances in Oncology and Radiotherapy | 2021-2025 | 75 | NL 3 | 93.60 |
| Effects of Radiation Exposure | 2021-2025 | 194 | NL 2 | 85.85 |
| Management of metastatic bone disease | 2021-2025 | 301 | NL 15 | 85.75 |
| Chemotherapy-induced cardiotoxicity and mitigation | 2021-2025 | 367 | NL 16 | 81.76 |
| Dupuytren's Contracture and Treatments | 2021-2025 | 76 | NL 7 | 68.61 |
| Boron Compounds in Chemistry | 2021-2025 | 960 | NL 3 | 50.27 |